Inventor · disambiguated record
Thomas R. Fuerst
Also filed as: FUERST THOMAS · FUERST THOMAS R
11 granted patents·8 pending applications·141 citations·filing 1988–2024
90Inventor score
Files withUNIV MARYLAND10GENELABS TECH INC3US COMMERCE3UNIV LELAND STANFORD JUNIOR1UNIV NEW YORK STATE RES FOUND1
Top patents by PatentIndex Score
19 records- 0179US10858483B2Polyphosphazene polyelectrolytes and uses thereofUNIV MARYLAND·Filed 2017·Granted Dec 8, 2020·1 cites·8 claims
- 0278US9732121B2Rational vaccine design for hepatitis C virusUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Aug 15, 2017·2 cites·7 claims
- 0378US5206353ACD-4/cytotoxic gene fusionsUS COMMERCE·Filed 1988·Granted Apr 27, 1993·26 cites·9 claims
- 0478US5135855ARapid, versatile and simple system for expressing genes in eukaryotic cellsUS HEALTH·Filed 1989·Granted Aug 4, 1992·49 cites·12 claims
- 0576US5587455ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1994·Granted Dec 24, 1996·28 cites·8 claims
- 0669US2023125630A1Polyphosphazenes, methods of making, and uses thereofUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 0765US11584828B2Polyphosphazene polyelectrolytes and uses thereofUNIV MARYLAND·Filed 2020·Granted Feb 21, 2023·0 cites·12 claims
- 0864US2025099570A1Antibodies targeting marburgvirus glycoproteins and uses thereofUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 0960US11472927B2Polyphosphazenes, methods of making, and uses thereofUNIV MARYLAND·Filed 2016·Granted Oct 18, 2022·0 cites·13 claims
- 1057US2024016923A1Modified secreted hepatitis c virus (hcv) e1e2 glycoproteins and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1156US2024100154A1Compositions and methods for producing glyco-modified viral antigensUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1254US5550035AProkaryotic expression in eukaryotic cellsUNIV NEW YORK STATE RES FOUND·Filed 1994·Granted Aug 27, 1996·16 cites·43 claims
- 1353US5428143ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1993·Granted Jun 27, 1995·9 cites·1 claims
- 1453US2022054630A1Modified hepatitis c virus e2 glycoproteins and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1551US2019321476A1Multifunctional biodegradable carriers for drug deliveryUNIV MARYLAND·Filed 2019·Application pending·0 cites
- 1650US2002107360A1Hepatitis E virus antigens and uses thereforGENELABS TECH INC·Filed 2001·Application pending·0 cites
- 1743US6291641B1Hepatitis E virus antigens and uses thereforGENELABS TECH INC·Filed 1995·Granted Sep 18, 2001·9 cites·1 claims
- 1842US2018311175A1Multifunctional biodegradable carriers for drug deliveryUNIV MARYLAND·Filed 2016·Application pending·0 cites
- 1931US6214970B1Hepatitis E virus antigens and uses thereforGENELABS TECH INC·Filed 1995·Granted Apr 10, 2001·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Thomas R. Fuerst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →